ArticleExperimental and therapeutic medicine2016
Non-intervention observation: Dynamic evolution laws of inflammatory response in necrotizing enterocolitis.
Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- A prediction model for neonatal necrotizing enterocolitis in preterm and very low birth weight infants.Frontiers in pediatrics · 2023Article
- TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6.Cell cycle (Georgetown, Tex.) · 2018Article
- Milk's Role as an Epigenetic Regulator in Health and Disease.Diseases (Basel, Switzerland) · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of necrotizing enterocolitis (NEC) is not well understood but immunological factors are thought to be key determinants of the disease appearance and its prognosis. During the course of the present study, different groups of newborn infants were observed and tested, to obtain an accurate image of values of pro- and anti-inflammatory cytokines at the onset, development and progression of neonatal NEC and to compare the values to those obtained during normal healthy development. All the infants in the study received standard medical treatment as appropriate. Initially, all the low birth weight premature infants born between June, 2014 and June, 2015 were tested on days 1, 3, 7, 10, 14, and 21 after birth, to obtain serum values of platelet activating factor (PAF), interleukin-1 (IL-1), tumor necrosis factor-α (TNF-α) and IL-10. In total, 150 low birth weight premature infants were included, and the incidence of NEC was 6.67% (10/150). For the comparison studies, 10 premature NEC infants of low birth weight, 15 premature normal infants, and 15 full-term normal infants born during the same period were enrolled in the study. The serum values of PAF, IL-1, TNF-α and IL-10 for these infants were detected on the same days after birth. PAF, IL-1 and TNF-α levels began to increase on days 1-3 after birth in premature infants, reached a peak on days 7-10, and declined to normal levels on days 14-21. Comparison differences in premature and full-term infants were statistically significant (P<0.01). Interleukin-10 began to increase on days 7-10 after birth in premature infants and reached a peak on days 14-21. Comparisons among premature and full-term infants at the given time points showed the differences were also statistically significant (P<0.01). The differences in values of the above inflammatory cytokines in the infants that died and the values in the survivors were not statistically significant (P>0.05). In conclusion, pro-inflammatory factors PAF, IL-1, TNF-α and anti-inflammatory factor IL-10 may be important in the pathogenesis of NEC, and monitoring their levels in blood can be useful in the prediction of the occurrence of disease. Nevertheless, these levels are not useful as prognostic markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.